Theradome receives FDA approval

11 May 2018

Medical device company, Theradome Inc, has received clearance from the Food and Drug Administration (FDA) for its LH80 PRO hair restoration device for men.

The Theradome for female use had already been cleared by the FDA in 2013. It aims to stimulate weak hair follicles and provide them with targeted laser energy. According to Theradome, this increases microcirculation bringing nutrients and oxygen to stimulate hair growth and to stop or slow hair loss.

Founder and CEO of Theradome, Tamim Hamid, said, “After endless attempts to try to regain my own hair, I decided to combine my experience as a NASA scientist along with my doctoral work in biomedical engineering, to create a solution that actually worked.”

He added, “We are pleased that we can help the millions of men around the globe who suffer from hair loss. This new level of clearance grants a broader audience access to an effective, less-expensive therapy that can be used in the comfort of their home."


Log-in to post a comment